Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
09/1998
09/02/1998EP0861078A1 Hemoregulatory compounds
09/02/1998EP0861077A1 Hemoregulatory compounds
09/02/1998EP0861076A1 Hemoregulatory compounds
09/02/1998EP0861074A1 Non-ionic surfactant vesicles as therapeutic agent
09/02/1998EP0861030A1 Hemoregulatory compounds
09/02/1998EP0861029A1 Hemoregulatory compounds
09/02/1998EP0686044B1 Inhibition of intimal hyperplasia using antibodies to pdgf receptors
09/02/1998EP0636173B1 Treatment of hiv-associated immune thrombocytopenic purpura
09/02/1998CN1191898A Self-enhancing, pharmacologically controllable expression systems
09/01/1998US5801162 Containing tissue plasminogen activator
09/01/1998US5801019 DNA encoding fused alpha-beta globin pseuodimer and production of pseudotetrameric hemoglobin
09/01/1998US5801017 Production of recombinant factor Xa inhibitor of leech Hirudo medicinalis
09/01/1998US5800819 Piper guineense, pterocarpus osun, eugenia caryophyllata, and sorghum bicolor extracts for treating sickle cell disease
08/1998
08/27/1998WO1998037240A1 Anti-sense oligonucleotide pharmacological agents
08/27/1998WO1998037094A2 Secreted proteins and polynucleotides encoding them
08/27/1998WO1998037075A1 Disubstituted bicyclic heterocycles, their production and use as medicaments
08/27/1998WO1998024782A3 Substituted pyrimidine compounds and their use
08/27/1998WO1998006437A3 Compositions and methods for polynucleotide delivery
08/27/1998DE19707508A1 Preparation of pure, stable haemoglobin
08/27/1998CA2281059A1 Secreted proteins and polynucleotides encoding them
08/26/1998EP0860445A1 New nucleotide sequences for the cell cycle regulated expression of structural genes
08/26/1998EP0859853A1 Method for transferring genes to the heart using aav vectors
08/26/1998EP0859844A1 Interleuken-3 (il-3) receptor agonists
08/26/1998EP0859842A1 SHORT FORMS OF CHEMOKINE $g(b)-8
08/26/1998EP0859784A1 Thio-substituted peptides as inhibitors for metalloproteinases and tnf liberation
08/26/1998EP0859771A1 Substituted pyridyl pyrroles, compositions containing such compounds and methods of use
08/26/1998EP0859634A1 Pharmaceutical compositions containing platelet aggregation inhibitors
08/26/1998EP0859628A1 Drug, in particular for modulating the immunological response for the control of viruses, tumours, bacteria and parasites
08/26/1998EP0859621A1 Biocompatible aqueous solution for use in continuous ambulatory peritoneal dialysis
08/26/1998EP0859613A2 Use of flupirtin for the prevention and treatment of diseases which are associated with damage to the haemopoietic cell system
08/26/1998EP0859607A1 Guanidino protease inhibitors
08/26/1998EP0506757B1 A recombinant human factor viii derivative
08/26/1998EP0479948B1 Compositions and methods for the synthesis of natriuretic protein receptor b and methods of use
08/26/1998CN1191545A Process of high purity albumin production
08/26/1998CN1191533A 1-benzoyl-2-(indolyl-3-alkyl)-piperazine derivs. as neurokinin receptor antagonists
08/25/1998US5798370 Anticoagulants
08/25/1998US5798357 Thromboxane synthetase inhibitors
08/25/1998US5798352 Antithrombotic amidinotetrahydropyridylalanine derivatives
08/25/1998US5798342 Use of natural cyclodextrins and their derivatives for the solubilization of platelet anti-aggregating agents from the family of ginkgolides
08/25/1998US5798332 Inhibiting thrombosis by administering reagent that binds carbohydrate in which sialic acid is linked to galactose or n-acetylgalactosamine through alpha2-6 linkage
08/25/1998US5798248 Recombinant mutant thrombin receptor and related pharmaceuticals
08/25/1998US5798227 Expressing the globulins in the same cell such that alpha and beta globulin-like polypeptides are assembled and combined with heme to produce a hemoglobin-like protein
08/20/1998WO1998036075A1 Variants of vascular endothelial cell growth factor having altered pharmacological properties, and related aspects thereof
08/20/1998WO1998035949A1 Bicyclic amino acids
08/20/1998WO1998035689A1 Expression of active human factor ix in mammary tissue of transgenic animals
08/20/1998WO1998035678A1 Use of cyanines, isocyanines and pseudoisocyanines as diuretics
08/20/1998DE19706161A1 Verwendung von Cyaninen, Isocyaninen und Pseudoisocyaninen als Diuretika Use of cyanines, Isocyaninen and Pseudoisocyaninen as diuretics
08/20/1998DE19705450A1 Bicyclische aromatische Aminosäuren Bicyclic aromatic amino acids
08/20/1998CA2281795A1 The use of cyanines, isocyanines, and pseudoisocyanines as diuretics
08/20/1998CA2280700A1 Expression of active human factor ix in mammary tissue of transgenic animals
08/20/1998CA2280209A1 Variants of vascular endothelial cell growth factor having altered pharmacological properties, and related aspects thereof
08/19/1998EP0858503A1 METHODS FOR USE OF Mpl LIGANDS WITH PRIMITIVE HUMAN STEM CELLS
08/19/1998EP0858464A1 Thrombin inhibitors
08/19/1998EP0858458A1 Antithrombotic n-amidinopiperidine and benzamidine derivatives
08/19/1998EP0858457A1 5-membered heterocycles, pharmaceutical agents containing said compounds and the use thereof and methods of producing them
08/19/1998EP0858337A2 A pharmaceutical composition for the treatment of autoimmune diseases
08/19/1998EP0765166A4 Radiolabeled annexin-galactose conjugates
08/19/1998EP0460058B1 Use of bactericidal/permeability increasing protein or biologically active analogs thereof for the manufacture of a medicament to treat endotoxin-associated disorders
08/19/1998CN1190589A Complex ferrous sulfate tablet
08/18/1998US5795954 Factor VIIa inhibitors from Kunitz domain proteins
08/18/1998US5795903 Anticonvulsants, antianxiety, schizophrenia, sleep disorders, brain disorders and alzheimer's or parkinson's disease
08/18/1998US5795893 Fibrinogen receptor antagonists
08/18/1998US5795892 Anticoagulants
08/18/1998US5795571 Coagulation
08/18/1998CA2224123A1 Nucleic acid construct for the cell cycle regulated expression of structural genes
08/18/1998CA2131455C Selective crosslinking of hemoglobin by oxidized, ring-opened saccharides
08/18/1998CA1340007C Linear analogs of atrial natruiretic peptides
08/13/1998WO1998034959A1 Dermatan disulfate, an inhibitor of thrombin generation and complement activation
08/13/1998WO1998034955A1 No-modified hemoglobins and uses therefor
08/13/1998WO1998034935A1 Fibrinogen receptor antagonist prodrugs
08/13/1998WO1998034929A1 Il-8 receptor antagonists
08/13/1998WO1998034919A1 2-amino-6-(2-substituted-4-phenoxy)-substituted-pyridines
08/13/1998WO1998034918A1 Arylsulfonyl hydroxamic acid derivatives
08/13/1998WO1998034910A1 Glycerolipidic compounds used for the transfer of an active substance into a target cell
08/13/1998WO1998034478A1 Methods and compositions for producing dried, storage-stable platelets
08/13/1998WO1998030693A3 Tumor necrosis factor receptor 5
08/13/1998WO1998025965A3 Peptides and compounds that bind to the thrombopoietin receptor
08/13/1998WO1998022501A3 Secreted proteins and polynucleotides encoding them
08/13/1998CA2280048A1 Il-8 receptor antagonists
08/13/1998CA2279927A1 Fibrinogen receptor antagonist prodrugs
08/13/1998CA2279376A1 Methods and compositions for producing dried, storage-stable platelets
08/13/1998CA2278784A1 No-modified hemoglobins and uses therefor
08/13/1998CA2251999A1 Glycerolipidic compounds used for the transfer of an active substance into a target cell
08/12/1998EP0857781A2 Human endoglingene promoter and use thereof
08/12/1998EP0857733A2 Hemoglobin having protecting ligands of oxygen binding positions as artificial oxygen carriers for direct biological or medicinal use and process for its preparation
08/12/1998EP0857489A2 Production and use of multimeric hemoglobins
08/12/1998EP0857207A1 Microporous pathogen-killing composition
08/12/1998EP0857175A1 Novel human cysteine protease
08/12/1998EP0783528B1 Method of producing starch decomposition products
08/12/1998EP0748215A4 Biologic bioadhesive compositions containing fibrin glue and liposomes, methods of preparation and use
08/12/1998EP0629211B1 4-oxo-2-thioxoimidazolidine derivates as inhibitors of blood platelet aggregation
08/12/1998EP0467991B1 Platelet membrane microparticles
08/12/1998CN1190395A Substituted (sulfinic acid, sulfonic acid, sulfonylamino or sulfinylamino) n-£(aminoiminomethyl) phenylalkyl|-azaheterocyclylamide compounds
08/12/1998CN1190348A Method for increasing hematopoietic cell
08/11/1998US5792772 Enatiomerically pure hydroxylated xanthine compounds
08/11/1998US5792629 Nucleotide and amino acid sequences
08/11/1998CA2083162C Enzymatic neutralization of heparin
08/11/1998CA1339992C Anticoagulant polypeptede
08/06/1998WO1998033920A2 Tissue factor pathway inhibitor-3
08/06/1998WO1998033916A2 Secreted proteins and polynucleotides encoding them
1 ... 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 ... 671